Debio-025 is more effective than prednisone in reducing muscular pathology in mdx mice
- 30 November 2010
- journal article
- Published by Elsevier BV in Neuromuscular Disorders
- Vol. 20 (11), 753-760
- https://doi.org/10.1016/j.nmd.2010.06.016
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1−/− myopathic miceBritish Journal of Pharmacology, 2009
- Cyclosporine A treatment for Ullrich congenital muscular dystrophy: a cellular study of mitochondrial dysfunction and its rescueBrain, 2009
- Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophyBritish Journal of Pharmacology, 2008
- Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathiesProceedings of the National Academy of Sciences of the United States of America, 2008
- Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophyNature Medicine, 2008
- Age-Dependent Effect of Myostatin Blockade on Disease Severity in a Murine Model of Limb-Girdle Muscular DystrophyThe American Journal of Pathology, 2006
- A Multidisciplinary Evaluation of the Effectiveness of Cyclosporine A in Dystrophic Mdx MiceThe American Journal of Pathology, 2005
- Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin/NF‐AT pathwayThe FASEB Journal, 2004
- The Dystrophin Glycoprotein ComplexCirculation Research, 2004
- The presence of two classes of high‐affinity cyclosporin A binding sites in mitochondriaJBIC Journal of Biological Inorganic Chemistry, 1990